|
|
Volumn 9, Issue 2, 2000, Pages 221-235
|
|
Recent progress in antiviral chemotherapy for respiratory syncytial virus infections
|
|
Author keywords
Acute respiratory infections; Antiviral chemotherapy; Monoclonal antibody; Respiratory syncytial virus; Ribavirin
|
|
Indexed keywords
5 ETHYNYL 4 IMIDAZOLECARBOXAMIDE 1 RIBOSIDE;
ANTISENSE OLIGONUCLEOTIDE;
ANTIVIRUS AGENT;
CROFELEMER;
JM 2926;
MIZORIBINE;
MONOCLONAL ANTIBODY;
NIH 8281;
NMS 03;
NUCLEOSIDE ANALOG;
PALIVIZUMAB;
PIRAZOFURIN;
PM 523 1001;
POLYOXOMETALATE;
RD3 0028;
RIBAVIRIN;
TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE;
UNCLASSIFIED DRUG;
V 590;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
BONE MARROW TOXICITY;
CARDIOPULMONARY HEMODYNAMICS;
DISEASE ASSOCIATION;
DRUG COST;
FEVER;
HUMAN;
IMMUNE SYSTEM;
INJECTION PAIN;
LUNG FUNCTION;
NERVOUSNESS;
NONHUMAN;
OTITIS MEDIA;
PREMATURITY;
RESPIRATORY TRACT INFECTION;
REVIEW;
VIRUS PATHOGENESIS;
WHEEZING;
|
|
EID: 0033982603
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.9.2.221 Document Type: Review |
|
Times cited : (43)
|
|
References (78)
|
